BioMarin
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
CEOAlexander Hardy
CEOAlexander Hardy
Employees3,040
Employees3,040
HeadquartersSan Rafael, California
HeadquartersSan Rafael, California
Founded1997
Founded1997
Employees3,040
Employees3,040
BMRN Key Statistics
Market cap10.09B
Market cap10.09B
Price-Earnings ratio19.69
Price-Earnings ratio19.69
Dividend yield—
Dividend yield—
Average volume2.22M
Average volume2.22M
High today$53.73
High today$53.73
Low today$52.36
Low today$52.36
Open price$52.65
Open price$52.65
Volume2.13M
Volume2.13M
52 Week high$73.51
52 Week high$73.51
52 Week low$50.76
52 Week low$50.76
Stock Snapshot
The current BioMarin(BMRN) stock price is $52.48, with a market capitalization of 10.09B. The stock trades at a price-to-earnings (P/E) ratio of 19.69.
As of 2025-11-20, BioMarin(BMRN) stock has fluctuated between $52.36 and $53.73. The current price stands at $52.48, placing the stock +0.2% above today's low and -2.3% off the high.
The BioMarin(BMRN)'s current trading volume is 2.13M, compared to an average daily volume of 2.22M.
During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.
During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.
Analyst ratings
79%
of 28 ratingsBuy
78.6%
Hold
21.4%
Sell
0%
People also own
Based on the portfolios of people who own BMRN. This list is generated using Robinhood data, and it’s not a recommendation.